Reference

AMET works diligently to keep the following information updated with the most current medical aesthetic news.  This information has been supplied by numerous sources. AMET is not affiliated with any such sources, and the information provided does not reflect the views of AMET.  The function of this page is to simply provide information, and AMET does not accept responsibility or liability for any views/claims/rumors/errors that appears herein.  

6/4/2015
Study examines storing, using reconstituted botulinum toxin A
Storing vials of reconstituted botulinum toxin A (Botox, Allergan) for four weeks after patient administration results in no detectable bacterial or fungal contamination, according to a new pilot study.
Study examines storing, using reconstituted botulinum toxin A

Storing vials of reconstituted botulinum toxin A (Botox, Allergan) for four weeks after patient administration results in no detectable bacterial or fungal contamination, according to a new pilot study.

Although findings of several studies indicated that reconstituted botulinum toxin A (BTX-A) retained efficacy during storage for several weeks, there was insufficient evidence that sterility was maintained for this duration. Regardless of potency, contamination remained a concern for physicians who treat patients with reconstituted BTX-A after the recommended period by the manufacturer, the studys lead author Teissy Osaki, M.D., and Ph.D. candidate at the division of ophthalmic plastic and reconstructive surgery, Federal University of So Paulo, So Paulo, Brazil, tells Cosmetic Surgery Times.

Dr. Osaki and colleagues evaluated the contents of 88 reconstituted vials of BTX-A after clinical administration of an aliquot and subsequent storage of the remaining contents under refrigeration for four weeks.

Research suggests the practice of storing and using reconstituted BTX-A is somewhat common.

an online survey of BTX-A utilization among members of the American Society for Dermatologic Surgery indicated that most physicians (68.6%) routinely store BTX-A for a longer period (more than one week after reconstitution) than the 24-hour period recommended by the manufacturer, Dr. Osaki says.

But this study by no means supports the practice. The authors of the study do not recommend utilizing reconstituted BTX-A beyond the period indicated by the manufacturer, according to Dr. Osaki.

Our study was a pilot study, Dr. Osaki says. Future multicentric studies that evaluate a larger number of vials and other possible contaminants are needed, and the results of these additional future studies may support the storage of reconstituted BTX-A for longer than the period recommended by the manufacturer.

Note: There were some errors in the published version and an erratum will be published in the next edition of Aesthetic Surgery Journal, according to Dr. Osaki.

http://cosmeticsurgerytimes.modernmedicine.com/cos...

back to reference main